TIAA Trust, National Association’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,408
Closed -$887K 475
2025
Q4
$887K Buy
10,408
+121
+1% +$9.93K ﹤0.01% 398
2025
Q3
$800K Sell
10,287
-578
-5% -$45.2K ﹤0.01% 417
2025
Q2
$850K Buy
10,865
+64
+0.6% +$4.77K ﹤0.01% 406
2025
Q1
$783K Sell
10,801
-142
-1% -$10.2K ﹤0.01% 396
2024
Q4
$810K Buy
10,943
+656
+6% +$45.9K ﹤0.01% 390
2024
Q3
$679K Buy
10,287
+154
+2% +$11.2K ﹤0.01% 414
2024
Q2
$936K Buy
10,133
+2,662
+36% +$236K ﹤0.01% 359
2024
Q1
$714K Sell
7,471
-3,678
-33% -$309K ﹤0.01% 395
2023
Q4
$850K Buy
11,149
+2,072
+23% +$144K ﹤0.01% 350
2023
Q3
$629K Buy
+9,077
New +$729K ﹤0.01% 392

Other funds holding EW

TIAA Trust, National Association's EW Position: Q1 2026 in Review

TIAA Trust, National Association sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 10,408 shares — an estimated $887K sold.

TIAA Trust, National Association first reported a position in EW in Q3 2023 and held it in 10 quarters. The position peaked at $936K in Q2 2024. 1,288 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • TIAA Trust, National Association reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
  • TIAA Trust, National Association sold 10,408 Edwards Lifesciences shares in Q1 2026, an estimated $887K.
  • TIAA Trust, National Association first reported a position in Edwards Lifesciences in Q3 2023 and held it in 10 quarters.
  • TIAA Trust, National Association's Edwards Lifesciences position peaked at $936K in Q2 2024.
  • 1,288 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on TIAA Trust, National Association's 13F filing for Q1 2026, filed 12 May 2026.